Search results
Results From The WOW.Com Content Network
Otitis externa responds well to treatment, but complications may occur if it is not treated. Individuals with underlying diabetes , disorders of the immune system, or history of radiation therapy to the base of the skull are more likely to develop complications, including malignant otitis externa. [ 23 ]
Malignant otitis externa is a rare and potentially life-threatening complication of otitis externa in which the infection spreads from the ear canal into the surrounding skull base, hence becoming an osteomyelitis. [16] It occurs largely in diabetic patients. [20]
The most common aetiology of acute otitis externa is bacterial infection, [5] while chronic cases are often associated with underlying skin diseases such as eczema or psoriasis. [6] A third form, malignant otitis externa, or necrotising otitis externa, is a potentially life-threatening, invasive infection of the external auditory canal and ...
Neomycin/polymyxin B/hydrocortisone, sold under the brand Otosporin among others, is a medication used to treat otitis externa (swimmer's ear) and certain eye disorders. [2] [3] It consists of the antibiotics neomycin and polymyxin B, and the steroid hydrocortisone. [3] It is used as an ear drop or eye drop. [2] [3]
Other more common conditions (e.g. otitis externa) may also present with these symptoms, but cholesteatoma is much more serious and should not be overlooked.If a patient presents to a doctor with ear discharge and hearing loss, the doctor should consider cholesteatoma until the disease is definitely excluded. [4]
Malignancy, malignant neoplasm and malignant tumor are synonymous with cancer; Malignant ascites; Malignant transformation; Non-oncologic disorders referred to as "malignant" include: Malignant hypertension; Malignant hyperthermia; Malignant otitis externa; Malignant tertian malaria (malaria caused specifically by Plasmodium falciparum)
Ceftazidime, sold under the brand name Fortaz among others, is a third-generation cephalosporin antibiotic useful for the treatment of a number of bacterial infections. [1] [5] Specifically it is used for joint infections, meningitis, pneumonia, sepsis, urinary tract infections, malignant otitis externa, Pseudomonas aeruginosa infection, and vibrio infection. [1]
Gradenigo's syndrome, also called Gradenigo-Lannois syndrome, [1] [2] is a complication of otitis media and mastoiditis involving the apex of the petrous temporal bone. It was first described by Giuseppe Gradenigo in 1904. [3]